The aim of this study was to determine the development of drug resistance among pregnant women receiving a protease inhibitor-based antiretroviral prophylaxis for the prevention of mother-to-child transmission of human immunodeficiency virus (HIV).
Department of Obstetrics and Gynecology, Medizinische Poliklinik, University Hospital of Munich, Downtown Campus, Munich, Germany. andrea.gingelmaier@med.uni-muenchen.de